Agios Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US00847X1046

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Marc Tessier-Lavigne. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Marc Tessier-Lavigne telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti Tajuk Pegangan Terkini Dilaporkan
US:DNLI / Denali Therapeutics Inc. Director 1,886,576
US:REGN / Regeneron Pharmaceuticals, Inc. Director 2,434
US:AGIO / Agios Pharmaceuticals, Inc. Director 48,875
US:JUNO / Juno Therapeutics, Inc. Director 12,000
US:PFE / Pfizer Inc. Director 29,100
Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Marc Tessier-Lavigne. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam AGIO / Agios Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam AGIO / Agios Pharmaceuticals, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
2013-07-24 AGIO Tessier-Lavigne Marc 55,555 18.0000 55,555 18.0000 999,990 331 49.5000 1,749,982 175.00

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

AGIO / Agios Pharmaceuticals, Inc. Insider Trades
Jualan Orang Dalam AGIO / Agios Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam AGIO / Agios Pharmaceuticals, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

AGIO / Agios Pharmaceuticals, Inc. Insider Trades
Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Marc Tessier-Lavigne seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah
Saham
harga
Tran
Nilai
Baki
Nilai
2025-06-05 2025-06-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 6,037 1,886,576 0.32
2024-06-04 2024-05-31 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 5,967 1,880,539 0.32
2023-06-05 2023-06-01 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 4,216 1,874,572 0.23
2023-01-05 2023-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 165 2,434 7.27
2023-01-05 2023-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 165 2,434 7.27
2022-11-28 2022-11-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -20,000 1,870,356 -1.06 30.48 -609,600 57,008,451
2022-11-03 2022-11-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -11,252 1,890,356 -0.59 30.33 -341,273 57,334,497
2022-11-03 2022-11-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8,748 1,901,608 -0.46 30.20 -264,190 57,428,562
2022-10-03 2022-10-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,612 2,269 -61.42 718.00 -2,593,416 1,629,142
2022-10-03 2022-10-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,612 5,881 159.19 413.33 1,492,948 2,430,794
2022-10-03 2022-09-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,428 2,269 -60.17 698.00 -2,392,744 1,583,762
2022-10-03 2022-09-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,428 5,697 151.08 413.33 1,416,895 2,354,741
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -20 2,269 -0.87 704.83 -14,097 1,599,259
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16 2,289 -0.69 702.36 -11,238 1,607,702
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -80 2,305 -3.35 699.82 -55,986 1,613,085
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -208 2,385 -8.02 698.44 -145,276 1,665,779
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -160 2,593 -5.81 697.29 -111,566 1,808,073
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -85 2,753 -3.00 696.13 -59,171 1,916,446
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -554 2,838 -16.33 691.59 -383,141 1,962,732
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -692 3,392 -16.94 690.65 -477,930 2,342,685
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,009 4,084 -19.81 689.56 -695,766 2,816,163
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -637 5,093 -11.12 688.71 -438,708 3,507,600
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -321 5,730 -5.30 687.90 -220,816 3,941,667
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16 6,051 -0.26 686.89 -10,990 4,156,371
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,798 6,067 167.39 413.33 1,569,827 2,507,673
2022-09-30 2022-09-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4,423 1,910,356 -0.23 31.08 -137,467 59,373,864
2022-09-30 2022-09-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -15,577 1,914,779 -0.81 30.74 -478,837 58,860,306
2022-08-25 2022-08-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -100 1,930,356 -0.01 32.43 -3,243 62,601,445
2022-08-25 2022-08-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -19,900 1,930,456 -1.02 31.61 -629,039 61,021,714
2022-07-27 2022-07-25 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -200 1,950,356 -0.01 36.15 -7,230 70,505,369
2022-07-27 2022-07-25 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -19,800 1,950,556 -1.00 35.60 -704,880 69,439,794
2022-06-28 2022-03-23 4/A DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -11,598 2,024,370 -0.57 34.14 -395,956 69,111,992
2022-06-28 2022-03-23 4/A DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -8,402 2,035,968 -0.41 33.40 -280,627 68,001,331
2022-06-27 2022-06-24 4 DNLI Denali Therapeutics Inc.
Common Stock
D - Sale to Issuer -6,766 1,970,356 -0.34 31.08 -210,261 61,230,980
2022-06-27 2022-06-24 4 DNLI Denali Therapeutics Inc.
Common Stock
D - Sale to Issuer -39,984 1,977,122 -1.98 30.53 -1,220,708 60,361,337
2022-06-27 2022-06-23 4 DNLI Denali Therapeutics Inc.
Common Stock
D - Sale to Issuer -13,250 2,017,106 -0.65 31.10 -412,076 62,732,198
2022-06-06 2022-06-02 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 5,986 2,030,356 0.30
2022-03-25 2022-03-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -11,598 2,024,370 -0.57 34.14 -395,956 69,111,992
2022-03-25 2022-03-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -8,402 2,035,968 -0.41 33.40 -280,627 68,001,331
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -7,439 0 -100.00
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,439 2,269 -76.63 690.00 -5,132,910 1,565,610
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,439 9,708 327.85 380.95 2,833,887 3,698,263
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -7,830 0 -100.00
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,830 2,269 -77.53 680.00 -5,324,400 1,542,920
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,830 10,099 345.09 376.69 2,949,483 3,804,192
2022-03-18 2022-03-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -4,361 0 -100.00
2022-03-18 2022-03-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,361 2,269 -65.78 675.00 -2,943,675 1,531,575
2022-03-18 2022-03-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4,361 6,630 192.20 374.12 1,631,537 2,480,416
2022-02-17 2021-12-13 5 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -200,000 2,044,370 -8.91
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 2,707 2,707
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 191 2,269 9.19
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -800 78,848 -1.00 45.72 -36,576 3,604,931
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -6,002 79,648 -7.01 45.31 -271,951 3,608,851
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -900 79,173 -1.12 45.71 -41,139 3,618,998
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -5,625 80,073 -6.56 45.31 -254,869 3,628,108
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3,377 78,848 -4.11 45.59 -153,957 3,594,680
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3,343 82,225 -3.91 45.13 -150,870 3,710,814
2021-12-30 2021-12-29 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -10,704 85,650 -11.11 43.88 -469,692 3,758,322
2021-12-30 2021-12-29 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -10,700 85,698 -11.10 43.87 -469,409 3,759,571
2021-12-30 2021-12-29 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -10,700 85,568 -11.11 43.88 -469,516 3,754,724
2021-12-30 2021-12-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3,646 96,354 -3.65 44.37 -161,773 4,275,227
2021-12-30 2021-12-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3,602 96,398 -3.60 44.38 -159,857 4,278,143
2021-12-30 2021-12-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3,732 96,268 -3.73 44.37 -165,589 4,271,411
2021-12-30 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift 100,000 100,000
2021-12-30 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift 100,000 100,000
2021-12-30 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift 100,000 100,000
2021-12-30 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -300,000 2,244,370 -11.79
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -3,784 0 -100.00
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,784 2,078 -64.55 665.00 -2,516,360 1,381,870
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,784 5,862 182.10 371.40 1,405,378 2,177,147
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -4,250 0 -100.00
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -4,250 0 -100.00
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -4,250 8,500 -33.33
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -139 2,078 -6.27 652.26 -90,664 1,355,396
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -249 2,217 -10.10 651.54 -162,233 1,444,464
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -56 2,466 -2.22 650.33 -36,418 1,603,714
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 2,522 -4.69 649.35 -80,519 1,637,661
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -381 2,646 -12.59 648.25 -246,983 1,715,270
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -425 3,027 -12.31 647.39 -275,141 1,959,650
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -354 3,452 -9.30 646.24 -228,769 2,230,820
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -61 3,806 -1.58 645.21 -39,358 2,455,669
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -844 3,867 -17.92 644.52 -543,975 2,492,359
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,549 4,711 -24.74 643.33 -996,518 3,030,728
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,645 6,260 -20.81 642.54 -1,056,978 4,022,300
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -952 7,905 -10.75 641.56 -610,765 5,071,532
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -981 8,857 -9.97 640.61 -628,438 5,673,883
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,260 9,838 -11.35 639.45 -805,707 6,290,909
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,098 11,098 -15.90 638.46 -1,339,489 7,085,629
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -816 13,196 -5.82 637.71 -520,371 8,415,221
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -816 14,012 -5.50 636.64 -519,498 8,920,600
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4,250 14,828 40.18 273.67 1,163,098 4,057,979
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4,250 14,828 40.18 273.67 1,163,098 4,057,979
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4,250 10,578 67.16 273.67 1,163,098 2,894,881
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -27,245 0 -100.00
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -27,830 0 -100.00
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -39,303 7,862 -83.33
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -700 2,544,370 -0.03 71.06 -49,744 180,810,565
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -93,678 2,545,070 -3.55 70.34 -6,589,779 179,032,949
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 27,245 2,638,748 1.04 19.50 531,278 51,455,586
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 27,830 2,611,503 1.08 18.92 526,544 49,409,637
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 39,303 2,583,673 1.54 18.00 707,454 46,506,114
2021-06-04 2021-06-02 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 6,222 6,222
2021-06-04 2021-06-02 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 2,074 2,544,370 0.08
2021-05-24 2021-05-24 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8,806 2,542,296 -0.35 60.02 -528,580 152,601,317
2021-05-24 2021-05-21 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -37,957 2,551,102 -1.47 60.13 -2,282,468 153,405,417
2021-05-05 2021-05-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -98 2,589,059 0.00 61.20 -5,998 158,450,411
2021-05-05 2021-05-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3,139 2,589,157 -0.12 60.08 -188,591 155,556,553
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6,184 2,592,296 -0.24 57.60 -356,167 149,303,288
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -29,593 2,598,480 -1.13 56.91 -1,684,019 147,869,103
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -14,223 2,628,073 -0.54 55.61 -790,884 146,136,627
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1,031 2,642,296 -0.04 71.35 -73,563 188,530,462
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3,482 2,643,327 -0.13 69.59 -242,309 183,946,483
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6,011 2,646,809 -0.23 68.50 -411,778 181,317,004
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -14,945 2,652,820 -0.56 67.57 -1,009,834 179,251,047
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18,316 2,667,765 -0.68 66.55 -1,219,003 177,550,432
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -37,445 2,686,081 -1.37 65.63 -2,457,665 176,298,240
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18,770 2,723,526 -0.68 64.36 -1,208,056 175,288,857
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 3,613 3,613
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 248 2,078 13.55
2020-06-18 2020-06-16 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -400,000 2,739,043 -12.74 26.10 -10,440,000 71,489,022
2020-06-05 2020-06-03 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 3,253 3,253
2020-06-05 2020-06-03 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 15,183 15,183
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -15,000 0 -100.00
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -100 1,830 -5.18 566.01 -56,601 1,035,798
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -900 1,930 -31.80 565.35 -508,815 1,091,126
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -6,600 2,830 -69.99 564.45 -3,725,370 1,597,394
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -6,375 9,430 -40.34 563.45 -3,591,994 5,313,334
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,025 15,805 -6.09 562.65 -576,716 8,892,683
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 15,000 16,830 819.67 177.82 2,667,300 2,992,711
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -9,279 0 -100.00
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,842 1,830 -81.08 400.16 -3,138,055 732,293
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -800 9,672 -7.64 399.41 -319,528 3,863,094
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -637 10,472 -5.73 398.71 -253,978 4,175,291
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9,279 11,109 507.05 50.91 472,394 565,559
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,000 1,830 -73.21 400.03 -2,000,150 732,055
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 6,830 273.22 57.11 285,550 390,061
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 4,361 4,361
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 320 1,830 21.19
2019-05-31 2019-05-30 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 27,245 27,245
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3,784 3,784
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
A - Award 323 1,510 27.21
2018-06-15 2018-06-13 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 27,830 27,830
2018-01-03 2018-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7,439 7,439
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Series A-1 Preferred Stock
C - Conversion -25,000 0 -100.00
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Common Stock
C - Conversion 25,000 3,139,043 0.80
2017-12-08 2017-12-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 47,165 47,165
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
6,228,086
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
6,228,086
2017-01-05 2017-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7,830 7,830
2016-06-23 2016-06-21 4 AGIO AGIOS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 8,500 48,875 21.05
2016-06-21 2016-06-17 4 JUNO Juno Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12,000 12,000
2016-01-06 2016-01-04 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 9,212 9,212
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -5,000 5,000 -50.00
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -500 1,187 -29.64 595.44 -297,720 706,787
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2,000 1,687 -54.24 593.64 -1,187,280 1,001,471
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1,000 3,687 -21.34 590.17 -590,170 2,175,957
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1,500 4,687 -24.24 584.07 -876,105 2,737,536
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 5,000 6,187 421.23 57.11 285,550 353,340
2015-06-25 2015-06-23 4 AGIO AGIOS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 11,262 40,375 38.68
2015-06-16 2015-06-12 4 JUNO Juno Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12,000 12,000
2015-04-24 2015-04-23 4 PFE PFIZER INC
Phantom Stock Units
A - Award 4,596 29,100 18.75 35.36 162,500 1,028,975
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3,000 9,279 -24.43
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -300 1,187 -20.17 424.44 -127,332 503,810
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1,100 1,487 -42.52 423.64 -466,004 629,953
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1,600 2,587 -38.21 420.33 -672,528 1,087,394
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3,000 4,187 252.74 50.91 152,730 213,160
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 10,838 10,838
2014-12-23 2014-12-23 4 JUNO Juno Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -175,000 0 -100.00
2014-12-23 2014-12-23 4 JUNO Juno Therapeutics, Inc.
Common Stock
C - Conversion 175,000 250,000 233.33
2014-12-18 3 JUNO Juno Therapeutics, Inc.
Common Stock
150,000
2014-12-18 3 JUNO Juno Therapeutics, Inc.
Common Stock
150,000
2014-08-27 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3,000 12,279 -19.63
2014-08-27 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -3,000 1,187 -71.65 352.20 -1,056,600 418,061
2014-08-27 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3,000 4,187 252.74 50.91 152,730 213,160
2014-08-27 2014-08-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1,387 15,279 -8.32
2014-08-27 2014-08-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -200 1,187 -14.42 351.62 -70,324 417,373
2014-08-27 2014-08-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1,387 1,387 50.91 70,612 70,612
2014-06-05 2014-05-30 4 AGIO AGIOS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 14,000 29,113 92.64
2014-04-28 2014-04-24 4 PFE PFIZER INC
Phantom Stock Units
A - Award 5,291 23,671 28.79 30.71 162,500 726,932
2014-04-03 2013-07-24 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
P - Purchase 55,555 101,009 122.22 18.00 999,990 1,818,162
2014-01-06 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 12,750 12,750
2013-12-06 2013-12-04 4 AGIO AGIOS PHARMACEUTICALS INC
Common Stock (right to buy)
A - Award 10,750 15,113 246.39
2013-07-23 3 AGIO AGIOS PHARMACEUTICALS INC
Common Stock
45,454
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -300 10,000 -2.91
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -500 10,300 -4.63
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1,700 10,800 -13.60
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1,700 10,800 -13.60
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -800 14,200 -5.33
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8,334 16,666 -33.34
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -300 0 -100.00 264.17 -79,251
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 300 300 57.11 17,133 17,133
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -500 0 -100.00 263.50 -131,750
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 500 500 57.11 28,555 28,555
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1,700 0 -100.00 262.49 -446,233
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1,700 1,700 57.11 97,087 97,087
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1,700 1,700 57.11 97,087 97,087
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1,700 0 -100.00 261.53 -444,601
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -800 0 -100.00 260.75 -208,600
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 800 800 57.11 45,688 45,688
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -8,334 0 -100.00 260.20 -2,168,507
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 8,334 8,334 50.91 424,284 424,284
2013-04-26 2013-04-25 4 PFE PFIZER INC
Phantom Stock Units
A - Award 4,544 17,794 34.29 30.26 137,500 538,436
2013-01-03 2013-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15,000 15,000
2012-04-27 2012-04-26 4 PFE PFIZER INC
Phantom Stock Units
A - Award 5,963 12,776 87.51 23.06 137,500 294,619
2012-01-04 2012-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15,000 15,000
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)